γ-Oryzanol from Rice Bran Antagonizes Glutamate-Induced Excitotoxicity in an In Vitro Model of Differentiated HT-22 Cells

Li-Chai Chen,Mei-Chou Lai,Tang-Yao Hong,I-Min Liu
DOI: https://doi.org/10.3390/nu16081237
IF: 5.9
2024-04-22
Nutrients
Abstract:The excessive activation of glutamate in the brain is a factor in the development of vascular dementia. γ-Oryzanol is a natural compound that has been shown to enhance brain function, but more research is needed to determine its potential as a treatment for vascular dementia. This study investigated if γ-oryzanol can delay or improve glutamate neurotoxicity in an in vitro model of differentiated HT-22 cells and explored its neuroprotective mechanisms. The differentiated HT-22 cells were treated with 0.1 mmol/L glutamate for 24 h then given γ-oryzanol at appropriate concentrations or memantine (10 μmol/L) for another 24 h. Glutamate produced reactive oxygen species and depleted glutathione in the cells, which reduced their viability. Mitochondrial dysfunction was also observed, including the inhibition of mitochondrial respiratory chain complex I activity, the collapse of mitochondrial transmembrane potential, and the reduction of intracellular ATP levels in the HT-22 cells. Calcium influx triggered by glutamate subsequently activated type II calcium/calmodulin-dependent protein kinase (CaMKII) in the HT-22 cells. The activation of CaMKII-ASK1-JNK MAP kinase cascade, decreased Bcl-2/Bax ratio, and increased Apaf-1-dependent caspase-9 activation were also observed due to glutamate induction, which were associated with increased DNA fragmentation. These events were attenuated when the cells were treated with γ-oryzanol (0.4 mmol/L) or the N-methyl-D-aspartate receptor antagonist memantine. The results suggest that γ-oryzanol has potent neuroprotective properties against glutamate excitotoxicity in differentiated HT-22 cells. Therefore, γ-oryzanol could be a promising candidate for the development of therapies for glutamate excitotoxicity-associated neurodegenerative diseases, including vascular dementia.
nutrition & dietetics
What problem does this paper attempt to address?
The paper aims to investigate whether γ-oryzanol can alleviate glutamate-induced excitotoxicity and explore its neuroprotective mechanisms in differentiated HT-22 cells. Specifically, the study focuses on whether γ-oryzanol can delay or improve neurodegenerative diseases associated with vascular dementia. Excitotoxicity caused by excessive glutamate activation is closely related to the development of vascular dementia. Therefore, the study evaluated the potential therapeutic effects of γ-oryzanol on this toxicity through an in vitro experimental model. The results indicate that γ-oryzanol has significant neuroprotective effects and may become a candidate drug for treating neurodegenerative diseases related to glutamate excitotoxicity, including vascular dementia.